PI-GEN (EALING) LTD

Company Registration Number:
15497981 (England and Wales)

Unaudited abridged accounts for the year ended 28 February 2025

Period of accounts

Start date: 17 February 2024

End date: 28 February 2025

PI-GEN (EALING) LTD

Contents of the Financial Statements

for the Period Ended 28 February 2025

Balance sheet
Notes

PI-GEN (EALING) LTD

Balance sheet

As at 28 February 2025


Notes
2025


£
Fixed assets
Tangible assets: 3 10,051
Investments: 4 576,603
Total fixed assets: 586,654
Current assets
Stocks: 21,944
Debtors:   128,728
Cash at bank and in hand: 43,279
Total current assets: 193,951
Creditors: amounts falling due within one year:   (850,421)
Net current assets (liabilities): (656,470)
Total assets less current liabilities: (69,816)
Total net assets (liabilities): (69,816)
Capital and reserves
Called up share capital: 100
Profit and loss account: (69,916)
Shareholders funds: (69,816)

The notes form part of these financial statements

PI-GEN (EALING) LTD

Balance sheet statements

For the year ending 28 February 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 24 April 2026
and signed on behalf of the board by:

Name: J S Bhogal
Status: Director

The notes form part of these financial statements

PI-GEN (EALING) LTD

Notes to the Financial Statements

for the Period Ended 28 February 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

PI-GEN (EALING) LTD

Notes to the Financial Statements

for the Period Ended 28 February 2025

2. Employees

2025
Average number of employees during the period 1

PI-GEN (EALING) LTD

Notes to the Financial Statements

for the Period Ended 28 February 2025

3. Tangible Assets

Total
Cost £
Additions 11,599
At 28 February 2025 11,599
Depreciation
Charge for year 1,548
At 28 February 2025 1,548
Net book value
At 28 February 2025 10,051

PI-GEN (EALING) LTD

Notes to the Financial Statements

for the Period Ended 28 February 2025

4. Fixed investments

Investments in subsidiaries £576,603.

PI-GEN (EALING) LTD

Notes to the Financial Statements

for the Period Ended 28 February 2025

5. Related party transactions

Name of the related party: Pyramid Pharma Pharmaceuticals Ltd
Relationship:
Common parent company and common directors
Description of the Transaction: As at 28 February 2025, the company is owed £55,053 (2024 - £nil) from Pyramid Pharma Pharmaceuticals Ltd. There are no fixed repayment terms and no interest is charged.
£
Balance at 28 February 2025 55,053
Name of the related party: Parmay (Fulham) Ltd
Relationship:
Common parent company and common directors
Description of the Transaction: As at 28 February 2025, the company is owed £7,978 (2024 - £nil) from Parmay (Fulham) Ltd. There are no fixed repayment terms and no interest is charged.
£
Balance at 28 February 2025 7,978
Name of the related party: The Learning Pharmacy Ltd
Relationship:
Common parent company and common directors
Description of the Transaction: As at 28 February 2025, the company is owed £150,000 (2024 - £nil) from The Learning Pharmacy Ltd. There are no fixed repayment terms and no interest is charged.
£
Balance at 28 February 2025 150,000
Name of the related party: Midhurst (Hanwell) Ltd
Relationship:
Common parent company and common directors
Description of the Transaction: As at 28 February 2025, the company owes £71,352 (2024 - £nil) to Midhurst (Hanwell) Ltd. There are no fixed repayment terms and no interest is charged.
£
Balance at 28 February 2025 71,352
Name of the related party: Ananta Pharma Ltd
Relationship:
Common parent company and common directors
Description of the Transaction: As at 28 February 2025, the company owes £120,000 (2024 - £nil) to Ananta Pharma Ltd. There are no fixed repayment terms and no interest is charged.
£
Balance at 28 February 2025 120,000